Breaking Barriers in Science: The Women of DoubleRainbow Biosciences
Landkind announces GRAS status for biosynthesized salidroside
Landkind delivers cognitive function boost with GRAS-approved pure salidroside supplement
2022: The year of acceleration
Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside
Double Rainbow ramps up production of ancient natural painkiller
Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications
NutraCast: Utilizing synthetic biology to preserve medicinal plants
DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE
Big Pharma’s Green Ambitions
Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech
